本文へ

This website uses cookies for usage measurement and traffic analysis purposes.
By clicking the "Agree" button or continuing to browse this site, you consent to the use of cookies.
For more details, please refer to the Privacy Policy別ウィンドウで開く (opens in a new window).

Agree

ATLAS Asia Clinical Trials Network for Cancers Project
menu
  1. Home
  2. International Medical Care
  3. NCC Today-Blog
  4. Endoscopic submucosal dissection aiming organ preservation

Endoscopic submucosal dissection aiming organ preservation

Seiichiro Abe

2023/6/15

Endoscopy Division actively performs endoscopic treatment, especially endoscopic submucosal dissection (ESD), to preserve organ function in patients with early gastrointestinal cancers (esophageal cancer, gastric cancer, duodenal cancer, and colorectal cancer). ESD enables reliable resection and accurate pathological diagnosis regardless of lesion size or location, and provides favorable treatment outcomes comparable to surgery in patients with low risk of nodal metastasis.
Our endoscopy center is one of the leading high-volume centers for gastrointestinal endoscopic treatment in Japan, and we are able to treat various patients, including those who are difficult to treat in general hospitals.


Picture 1:Extensive superficial esophageal cancer 

Picture 2:En bloc resection with ESD

Picture 3:The resected specimen
PAGE TOP